Insights

Innovative Oncology Focus Eisai's strong emphasis on oncology and neurodegenerative diseases presents significant sales opportunities in specialized pharmaceutical segments, especially as the company continues to develop and commercialize advanced therapies like Lecanemab and LEQEMBI.

Expansion in Europe The recent launch of Leqembi in Austria and upcoming introductions in Germany indicate opportunities to support continent-wide distribution, marketing, and customer engagement efforts in the European pharmaceutical market.

Recognition and Awards Eisai's recent accolades, including the Bioindustry Award and MedTech Breakthrough recognition, highlight its innovative drug development and patient care solutions, positioning it as a leader to partner with for advanced healthcare technologies.

Strong Industry Collaborations Partnerships with companies like Biogen and participation in major conferences signal opportunities to offer complementary digital health tools, care coordination platforms, and product support solutions for enhanced patient management.

Digital Tech Adoption Eisai's utilization of advanced technology stacks and digital tools positions it as a receptive partner for innovative sales platforms, telehealth solutions, and data-driven patient engagement solutions to further extend its market reach.

Eisai US Tech Stack

Eisai US uses 8 technology products and services including Kubernetes, Amazon CloudFront, Cloudflare CDN, and more. Explore Eisai US's tech stack below.

  • Kubernetes
    Containerization
  • Amazon CloudFront
    Content Delivery Network
  • Cloudflare CDN
    Content Delivery Network
  • Microsoft PowerPoint
    Editors
  • yepnope.js
    Javascript Frameworks
  • Video.js
    Javascript Libraries
  • Coupa
    Travel And Expense Management
  • Apache
    Web Servers

Media & News

Eisai US's Email Address Formats

Eisai US uses at least 1 format(s):
Eisai US Email FormatsExamplePercentage
First_Last@eisai.comJohn_Doe@eisai.com
92%
FLast@eisai.comJDoe@eisai.com
7%
First.Last@eisai.comJohn.Doe@eisai.com
1%

Frequently Asked Questions

Where is Eisai US's headquarters located?

Minus sign iconPlus sign icon
Eisai US's main headquarters is located at 200 Metro Blvd., Nutley, NJ 07110, US. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Eisai US's phone number?

Minus sign iconPlus sign icon
You can contact Eisai US's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Eisai US's stock symbol?

Minus sign iconPlus sign icon
Eisai US is a publicly traded company; the company's stock symbol is ESALY.

What is Eisai US's official website and social media links?

Minus sign iconPlus sign icon
Eisai US's official website is eisai.com and has social profiles on LinkedIn.

How much revenue does Eisai US generate?

Minus sign iconPlus sign icon
As of October 2025, Eisai US's annual revenue is estimated to be $5B.

What is Eisai US's NAICS code?

Minus sign iconPlus sign icon
Eisai US's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Eisai US have currently?

Minus sign iconPlus sign icon
As of October 2025, Eisai US has approximately 2.8K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer, Senior Vice President, Head Of Global Medical Affairs, Neurology: H. H.Chief Financial Officer: B. H.Chief Clinical Officer, Deep Human Biology Learning (dhbl): L. K.. Explore Eisai US's employee directory with LeadIQ.

What industry does Eisai US belong to?

Minus sign iconPlus sign icon
Eisai US operates in the Pharmaceutical Manufacturing industry.

What technology does Eisai US use?

Minus sign iconPlus sign icon
Eisai US's tech stack includes KubernetesAmazon CloudFrontCloudflare CDNMicrosoft PowerPointyepnope.jsVideo.jsCoupaApache.

What is Eisai US's email format?

Minus sign iconPlus sign icon
Eisai US's email format typically follows the pattern of First_Last@eisai.com. Find more Eisai US email formats with LeadIQ.

When was Eisai US founded?

Minus sign iconPlus sign icon
Eisai US was founded in 1995.

Eisai US

Pharmaceutical ManufacturingUnited States1001-5000 Employees

At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.

Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US.

Comments and posts by users on this site are not created or controlled by Eisai Inc. and Eisai is not responsible for such content.

Section iconCompany Overview

Headquarters
200 Metro Blvd., Nutley, NJ 07110, US
Phone number
Website
eisai.com
Stock Symbol
ESALY
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1995
Employees
1001-5000

Section iconFunding & Financials

  • $1B$10B

    Eisai US's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Eisai US's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.